1. Syed I, Aldren C. Meniere's disease: an evidence based approach to assessment and management. Int J Clin Pract. 2012;66(2):166-70.
2. Gottshall KR, Hoffer ME, Moore RJ, Balough BJ. The role of vestibular rehabilitation in the treatment of Meniere's disease. Otolaryngol Head Neck Surg. 2005;133(3):326-8.
3. Shepard NT. Differentiation of Meniere's disease and migraine-associated dizziness: a review. J Am Acad Audiol. 2006;17(1):69-80.
4. Gottshall KR, Topp SG, Hoffer ME. Early vestibular physical therapy rehabilitation for Meniere's disease. Otolaryngol Clin North Am. 2010;43(5):1113-9.
5. Valente M, Mispagel K, Valente LM, Hullar T. Problems and solutions for fitting amplification to patients with Meniere's disease. J Am Acad Audiol. 2006;17(1):6-15.
6. Ghazizadeh Hashemi SA, Jafarzadeh S, Haddadi Aval M, Hosseinabadi R. Ocular Motor Function in Patients with Bilateral Vestibular Weakness. Iran J Otorhinolaryngol. 2016;28(86):177-81.
7. Venosa AR, Bittar RS. Vestibular rehabilitation exercises in acute vertigo. Laryngoscope. 2007;117(8):1482-7.
8. Brown KE, Whitney SL, Wrisley DM, Furman JM. Physical therapy outcomes for persons with bilateral vestibular loss. Laryngoscope. 2001;111(10):1812-7.
9. Garcia AP, Gananca MM, Cusin FS, Tomaz A, Gananca FF, Caovilla HH. Vestibular rehabilitation with virtual reality in Meniere's disease. Braz J Otorhinolaryngol. 2013;79(3):366-74.
10. Whitney SL, Wrisley DM, Marchetti GF, Furman JM. The effect of age on vestibular rehabilitation outcomes. Laryngoscope. 2002;112(10):1785-90.
11. Adrion C, Fischer CS, Wagner J, Gurkov R, Mansmann U, Strupp M. Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). Bmj. 2016;352:h6816.
12. Karapolat H, Celebisoy N, Kirazli Y, Bilgen C, Eyigor S, Gode S, et al. Does betahistine treatment have additional benefits to vestibular rehabilitation? Eur Arch Otorhinolaryngol. 2010;267(8):1207-12.
13. Boleas-Aguirre MS, Sanchez-Ferrandiz N, Guillen-Grima F, Perez N. Long-term disability of class A patients with Meniere's disease after treatment with intratympanic gentamicin. Laryngoscope. 2007;117(8):1474-81.
14. Harner SG, Driscoll CL, Facer GW, Beatty CW, McDonald TJ. Long-term follow-up of transtympanic gentamicin for Meniere's syndrome. Otol Neurotol. 2001;22(2):210-4.